PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 Apr 2013 16:28

RNS Number : 2767D
Advanced Oncotherapy PLC
25 April 2013
 



 

TR-1: Notifications of Major Interests in Shares

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Advanced Oncotherapy plc

 

2. Reason for notification (yes/no)

 

An acquisition or disposal of voting rights

x

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An event changing the breakdown of voting rights

 

Other (please specify):__________

 

3. Full name of person(s) subject to notification obligation:

Peter Gyllenhammar

 

4. Full name of shareholder(s) (if different from 3):

Bronsstädet AB

Union Discount Company of London Ltd

 

5. Date of transaction (and date on which the threshold is crossed or reached if different):

2013-04-24/25

 

6. Date on which issuer notified:

 

7. Threshold(s) that is/are crossed or reached:

Below 3%

 

8: Notified Details

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code

ORDINARY

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

14806272

Number of voting rights

14806272

Number of shares

0

Number of voting rights

Percentage of voting rights

 

Direct

0

 

 

Indirect

 

Direct

0

 

Indirect

 

 

 

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

 

 

 

 

Total (A+B)

 

Number of voting rights

Percentage of voting rights

0

0

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

 

Peter Gyllenhammar is the 100% owner of the following companies owning the shares in Advanced Oncotherapy plc

Bronsstädet AB

Union Discount Company of London plc

 

Proxy Voting:

 

10. Name of proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14 Contact name:

 

Peter Gyllenhammar

15. Contact telephone name:

 

0046 708 185244

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVUVROSASUAR
Date   Source Headline
8th Aug 20147:00 amRNSIssue of Equity and Warrants and director deal
25th Jul 201411:39 amRNSResult of AGM
25th Jul 20147:00 amRNSAGM Statement
22nd Jul 20147:00 amRNSNew Contract Signed with ScandiNova
16th Jul 201410:59 amRNSChange of Adviser
14th Jul 20147:00 amRNSContract Signed with global IT leader ICT
30th Jun 20141:16 pmRNSSector Reclassification
30th Jun 20147:00 amRNSFinal Results
23rd Jun 20147:00 amRNSAdvanced Oncotherapy Announce New American Entity
4th Jun 201411:19 amRNSHolding(s) in Company
2nd Jun 20147:00 amRNSAppointment of New CEO
20th May 20147:00 amRNSAVO features in CNY Business Journal
30th Apr 20147:01 amRNSDirector deals and Share Option Scheme
28th Apr 20147:00 amRNSAppointment of Director of Project Planning
17th Apr 201410:41 amRNSPLacing and Subscription
25th Mar 20147:00 amRNSConversion of Loan
10th Mar 20147:00 amRNSPresenting at National Proton Conference
20th Feb 20147:00 amRNSNew Board Appointment
6th Feb 20147:01 amRNSNew Medical Advisory Board Appointment
16th Jan 20147:00 amRNSChange of Nomad and Broker
9th Jan 20148:58 amRNSIssue of Equity
4th Dec 20137:00 amRNSCollider Exhibition at Science Museum
26th Nov 20137:00 amRNSAppointment of Bob Rose
22nd Nov 20137:00 amRNSAppointment of Executive Director
6th Nov 201312:08 pmRNSIssue of Equity
31st Oct 20137:00 amRNSDr Jay Loeffler Joins Medical Advisory Board
25th Oct 20137:00 amRNSBoard Changes
3rd Oct 20137:00 amRNSAppointment to Advisory Board and Issue of Equity
1st Oct 20137:00 amRNSAppointment of Director, Issue of Equity
25th Sep 20137:01 amRNSHalf Yearly Report
25th Sep 20137:00 amRNSAcquisition
18th Sep 20137:00 amRNSCollaboration Agreement
30th Aug 20137:15 amRNSDirectorate Change
23rd Aug 201312:14 pmRNSDirectorate Change
20th Aug 20137:00 amRNSCollaboration with Spire Healthcare
26th Jul 201312:17 pmRNSReplacement: Result of AGM
25th Jul 20135:37 pmRNSResult of AGM
19th Jul 201312:18 pmRNSHolding(s) in Company
10th Jul 20137:00 amRNSIssue of Equity
28th Jun 201312:23 pmRNSFinal Results
27th Jun 20137:00 amRNSIssue of Equity
4th Jun 201310:03 amRNSResult of Meeting
3rd Jun 20137:00 amRNSCollaboration with BMI Healthcare
16th May 20137:00 amRNSPosting of Circular
3rd May 20137:00 amRNSDirector Appointment
30th Apr 20137:00 amRNSHolding(s) in Company
26th Apr 201312:21 pmRNSDirector Dealing
26th Apr 20137:00 amRNSDirector Appointment
26th Apr 20137:00 amRNSDirector Dealing
25th Apr 20134:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.